Use of topical rapamycin in facial angiofibromas in Indian skin type
Introduction: Facial angiofibromas (FA) are the most visible cutaneous manifestations in patients with tuberous sclerosis (TS), often resulting in stigmatization of the affected individuals. Recent studies have suggested that topical rapamycin may be an effective treatment for angiofibromas. Aim: To...
Main Authors: | Vishalakshi Viswanath, Parul Thakur, Poonam Pund |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Indian Journal of Dermatology |
Subjects: | |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2016;volume=61;issue=1;spage=119;epage=119;aulast=Viswanath |
Similar Items
-
Topical rapamycin (sirolimus) for facial angiofibromas
by: Bhushan Madke
Published: (2013-01-01) -
Facial angiofibromas of tuberous sclerosis treated with topical sirolimus in an Indian patient
by: Resham J Vasani
Published: (2015-01-01) -
Topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis: a systematic review based on evidence
by: Clara Cortell Fuster, et al.
Published: (2022-05-01) -
Impact of facial angiofibromas in tuberous sclerosis complex and reported efficacy of available treatments
by: Marie Monaghan, et al.
Published: (2022-08-01) -
Dermoscopy of Facial Angiofibromas in Four Patients of Skin of Color with Tuberous Sclerosis Complex: A Case-Series
by: Rashmi Jindal, et al.
Published: (2021-07-01)